Decade-Long Legal Battle Focused On Journal Cost, Impact

Editor's Note: For the past two decades, librarians have used citation data to rank journals. When library budgets were seemingly unlimited, journals published both by nonprofit professional societies and by for-profit publishers were purchased, often regardless of their intrinsic value or cost-effectiveness. In the past decade, under severe budget constraints, university librarians-with the advice of faculty-have had to "de-accession" hundreds of journals that, by one test or another, could

Written byAlbert Henderson
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Editor's Note: For the past two decades, librarians have used citation data to rank journals. When library budgets were seemingly unlimited, journals published both by nonprofit professional societies and by for-profit publishers were purchased, often regardless of their intrinsic value or cost-effectiveness. In the past decade, under severe budget constraints, university librarians-with the advice of faculty-have had to "de-accession" hundreds of journals that, by one test or another, could no longer be justified. As an extension of the quantitative methods of evaluation originally reported in my "Significant Journals of Science" (Nature, 264:60915, 1976), it was inevitable that peer judgments of journal quality would be combined with bibliometric indicators, such as the number of articles published (productivity) and average frequency of citation (impact). In 1988, Henry H. Barschall-a retired professor of physics at the University of Wisconsin, Madison, and a member of the American Institute of Physics' (AIP's) Publishing Policy Committee-published ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies